Skip to main content
Menu
search

Regulatory Challenges: Product Quality (CMC) Challenges and Opportunities

Regulatory Challenges: Product Quality (CMC) Challenges and Opportunities

Industry:
Biopharma

Type:
Podcast

Location:
Miami, Florida

The promise of cell and gene therapies is tempered by the challenges associated with achieving patient access. For autologous cell therapies, we know that shortening the time between starting material collection and patient dosing leads to improved clinical outcomes. Accelerated clinical programs create compressed timelines for CMC activities and development of robust process controls. Carol Houts from Germfree and David Lewandowski from Azenta will be discussing some of the unique CMC regulatory challenges found with cell therapy products produced using a distributed or POC manufacturing models.

You might also be interested in

Video

Inside the Innovation: Mobile CL-2 Laboratory Walkthrough

Discover how our team's design and engineering efforts have created a versatile solution for various processes and applications.
Articles

Optimizing Pharmaceutical Isolator Design

This article delves into the world of isolators, exploring their importance in the pharmaceutical and biotech industries, the challenges of innovating aseptic isolator design, best practices, key aspects of design…
Constructing Capabilities: Holistic Infrastructure Development in Decentralized Manufacturing
Video

Constructing Capabilities: Holistic Infrastructure Development in Decentralized Manufacturing

Dive into this discussion around decentralized manufacturing and the importance of designing identical and cloned processes, focusing on a copy-paste model for multiple locations.

Contact us: Let's unlock your scientific potential together

Complete our contact form and a member of our commercial team will contact you within 24 hours.

White email icon on a green diamond

Service & support: cs@germfree.com